Skip to main content
. Author manuscript; available in PMC: 2011 Apr 1.
Published in final edited form as: Ther Drug Monit. 2010 Apr;32(2):206–215. doi: 10.1097/FTD.0b013e3181d0bd68

Table 1.

Demographics and self-reported drug use history for the past 30 days prior to admission, and buprenorphine (BUP) doses for 5 opioid-dependent pregnant women.

Participant A B C D E Mean±SE
Age (years) 30 32 32 28 31 30.6±0.8
Race AAa AA AA AA AA -
Years education 10 10 12 8 10 10.0±0.6
Employment No No No No No -
EGAb 25 20 26 18 26 23.0±1.7
Cocaine use Yes Yes Yes Yes Yes -
Opioidusec 1 2 2 1 2 -
Alcohol use (days) 0 5 0 0 0 1.0±1.0
Smoking (days) 0 30 30 0 30 18.0±7.4
# cigarettes/day 0 3 20 0 10 6.6±3.8
Days in study at delivery 92 118 111 151 98 114.0±10.3
BUP dose at delivery (mg/day) 18 24 18 18 14 18.4±1.6
Mean daily BUP dose (mg/day) 15.9 18.3 15.9 12.3 13.6 15.2±1.0
Mean 3rd trimester daily BUP dose (mg/day) 16.9 21.8 17.1 13.3 13.7 16.6±1.5
Mean last month daily BUP dose (mg/day) 18 24 18 18 14 18.4±1.6
Cumulative BUP dose (mg) 1464 2160 1760 1850 1330 1712.8±146.5
Cumulative 3rd trimester BUP dose (mg) 1084 1396 1330 1132 1162 1220.8±60.3
Cumulative last month BUP dose (mg) 558 766 522 522 434 560.4±55.3
a

African-American

b

Estimated gestational age at admission (weeks)

c

Opioid use in the past 30 days at admission. 1 ≤ 3/day; 2≥ 4/day